← Back to Search

Financial Incentives for Contraceptive Use (M-CARES Trial)

N/A
Waitlist Available
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
. 18-35 years old,
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 year post-enrollment
Awards & highlights

M-CARES Trial Summary

This trial will estimate the impact of financial access to contraception on a variety of outcomes like childbearing, education, mental health, etc.

Who is the study for?
The trial is for individuals aged 18-35 who are not pregnant, do not wish to become pregnant in the next year, are biologically female and fertile, sexually active with men, and face out-of-pocket costs for contraceptives at PPMI.Check my eligibility
What is being tested?
M-CARES is testing the impact of financial access to contraception. Participants will receive gift cards covering either 50% or 100% of a name-brand IUD's cost. The study aims to understand how this affects various life aspects.See study design
What are the potential side effects?
This trial does not involve medical interventions that typically have side effects; however, using an IUD can sometimes cause discomfort, cramping or spotting. Financial incentives may also affect personal decisions.

M-CARES Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 35 years old.

M-CARES Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 year post-enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 year post-enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of childbirth up to 1 year post enrollment
Incidence of childbirth up to 3 year post enrollment
Incidence of patients billing for long-run acting, reversible contraception (LARC) (0 no use of LARC/1 for use of LARC)
+3 more

M-CARES Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment GroupExperimental Treatment2 Interventions
Women in this arm of the study receive a voucher which can be used to buy contraception and related services at Planned Parenthood
Group II: Control GroupActive Control1 Intervention
Women in this arm of the study DO NOT receive a voucher for contraceptives. Women in this arm receive the Planned Parenthood standard of care priced according to the Planned Parenthood sliding scale.

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,795 Previous Clinical Trials
6,369,303 Total Patients Enrolled
National Opinion Research CenterOTHER
12 Previous Clinical Trials
239,562 Total Patients Enrolled

Media Library

Gift card to be used for contraceptives that is valued at 100% of cost of name-brand IUD (March 4, 2019-December 31, 2021) Clinical Trial Eligibility Overview. Trial Name: NCT03673007 — N/A
Pregnancy Research Study Groups: Treatment Group, Control Group
Pregnancy Clinical Trial 2023: Gift card to be used for contraceptives that is valued at 100% of cost of name-brand IUD (March 4, 2019-December 31, 2021) Highlights & Side Effects. Trial Name: NCT03673007 — N/A
Gift card to be used for contraceptives that is valued at 100% of cost of name-brand IUD (March 4, 2019-December 31, 2021) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03673007 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must a person meet to be eligible for participation in this trial?

"This trial is searching for 5000 pregnant women aged between 18 and 35. To be eligible, patients must satisfy the following conditions: biologically female and fertile; not expecting a child in the near future; have sexual relations with men; and face some financial responsibility when obtaining contraceptives from PPM."

Answered by AI

Does this trial encompass participants aged 50 and over?

"The age restrictions for this trial indicate that only individuals between 18 and 35 are allowed to participate. Although, those outside of this range can find 21 trials tailored to minors or 34 clinical studies catered towards the elderly population."

Answered by AI

How many locations are participating in this experiment?

"9 medical centres are offering the trial, including Planned Parenthood - Warren (Warren), Planned Parenthood - Ferndale (Ferndale) and Planned Parenthood - Grand Rapids (Grand Rapids). Additionally, 6 other sites have been approved."

Answered by AI

How many subjects are involved in the experiment?

"Affirmative. Clinicaltrials.gov attests that recruitment for this medical trial opened on August 26th 2018 and was last updated on February 7th 2022; the study is looking to source 5000 participants from 9 sites in total."

Answered by AI

Does this research endeavor have room for additional participants?

"Affirmative. The clinical trial is recruiting participants, as indicated on the information hosted on clinicaltrials.gov; it was initially posted in August of 2018 and most recently updated in February 2022. This research requires 5000 patients to be enrolled from 9 distinct sites."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Michigan Contraceptive Access, Research, and Evaluation Study: Phase 1
Martha Bailey 2018. "Michigan Contraceptive Access, Research, and Evaluation Study: Phase 1". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03673007.
~2092 spots leftby Dec 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top